Table 1 Baseline demographic, clinical, and histological characteristics
Characteristic | Patients (n = 46) |
|---|---|
Age, years | 56 (49–61) |
Menopausal status | |
 Premenopausal | 13 (28%) |
 Postmenopausal | 33 (72%) |
Body mass index, kg/m2 | 22.7 (20.5–25.1) |
Time interval from surgery to recurrence, months | 94 (56–130) |
Pathology of the primary carcinoma | |
 Invasive ductal carcinoma | 44 (96%) |
 Invasive lobular carcinoma | 2 (4%) |
Pathological diagnosis of suspected recurrence or metastatic lesions | |
 Regional lymph node*†| 19 (41%) |
 Distant lymph node†| 10 (22%) |
 Lung†| 9 (20%) |
 Chest wall†| 6 (13%) |
 Pleura†| 1 (2%) |
 Chronic granulomatous inflammation | 1 (2%) |
ER Allred score‡ | |
 0–2 | 4 (9%) |
 3–6 | 9 (20%) |
 7–8 | 31 (71%) |
Progesterone receptor‡ | |
 Positive | 18 (41%) |
 Negative | 23 (52%) |
 Not assessed | 3 (7%) |
HER2‡ | |
 Positive | 5 (11%) |
 Negative | 34 (77%) |
 Not assessed | 5 (11%) |